Sentences with phrase «product liability litigation by»

The firm was also recognized for its strength in Product Liability Litigation by The BTI Consulting Group.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.

Important factors that could cause actual results to differ materially from those expressed or implied by such forward - looking statements include, without limitation, possible product defects and product liability, risks related to international sales and potential foreign currency exchange fluctuations, the initiation or outcome of litigation, acts or potential acts of terrorism, international conflicts, significant fluctuations of quarterly operating results, changes in Canadian and foreign laws and regulations, continued acceptance of RIM's products, increased levels of competition, technological changes and the successful development of new products, dependence on third - party networks to provide services, dependence on intellectual property rights, and other risks and factors detailed from time to time in RIM's periodic reports filed with the United States Securities and Exchange Commission, and other regulatory authorities.

Among his other distinctions, Stewart has been recognized by The Best Lawyers in America for the areas of Medical Malpractice Law (2013 — present), Personal Injury Litigation (2014 — present) and Product Liability Litigation (2016 — present).

Our litigation and trial lawyers are experienced with the common and statutory laws involving the prospective liability of manufacturers, distributors, and sellers of products to purchasers, users, and bystanders for personal injury and property damage caused by alleged defects in those products.

Jack Wurgaft, certified by the Supreme Court of New Jersey as a Civil Trial Lawyer, limits his practice to complex civil litigation, medical malpractice, products liability (MDL) and construction site accidents.

He is honoured to have been selected as a Lexpert Ranked Lawyer for Product liability and selected by his peers for Best Lawyers 2017 for Insurance, as well as in Expert Guides in the areas of Litigation, Product Liability, Insurance and Reiliability and selected by his peers for Best Lawyers 2017 for Insurance, as well as in Expert Guides in the areas of Litigation, Product Liability, Insurance and ReiLiability, Insurance and Reinsurance.

She has been internationally recognized as one of the leading lawyers in the area of product liability litigation throughout Asia and was recognized as a prominent female lawyer by Global Business Magazine's Women in Law Report - Top Women Lawyers 2012.

David has more than 35 years of jury trial, products liability, and insurance litigation experience and is board certified in civil trial law and in civil pretrial practice advocacy by the National Board of Legal Specialty Certification.

The Best Lawyers in America by Woodward White, Inc. listed Banks as the «2016 Birmingham Lawyer of the Year for Product Liability Litigation Defendants»

In 2016, she was appointed as a PSC member by the Honorable Kathryn Vratil in In Re: Ethicon, Inc., Power Morcellator Products Liability Litigation (D. Kansas, MDL No. 2652) and appointed as a PSC member by the Honorable Freda Wolfson in In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation (D. New Jersey, MDL No. 2738).

Drawing on attorneys from across practice areas and offices, Weil has developed an impressive track record advising with respect to shareholder claims and demands for litigation, internal whistleblower complaints, class and collective actions brought by employees relating to pay, worker classification, and discrimination claims, product liability issues and recalls, privacy rights, intellectual property disputes (patents, trademarks, copyrights, and trade secrets), regulatory investigations commenced by the U.S. Federal Trade Commission, U.S. Department of Labor, U.S. Department of Justice, and state attorneys general, and major disputes with suppliers and competitors.

It might start by working on communications issues surrounding damaged credibility, management transitions, bankruptcies, litigation, regulatory actions, rumour management, earnings shortfalls, restructurings and product liability situations.

These law firms were a reaction to the rise in Plaintiff's law firms retooled to gather the technical information and expertise (often gathered by government agencies and burgeoning universities fueled by GI Bill enrollment) that was needed to prosecute product liability cases and mass torts and to manage massive amounts of discovery and class action lawsuit in this complex litigation.

By investing time to understand the client's business and industry, we are able to apply our extensive product liability experience in a way that meets each client's specific needs and to develop a cost - effective approach to litigation management and resolution.

When you choose our Actos lawyer, you choose representation by some of the top attorneys in the country who have a proven record of success in products liability litigation.

Hughes Hubbard's Product Liability and Mass Tort group is widely recognized by leading legal publications, jurists, clients and the products bar at large as a «go to» defense team for a company's most complex and challenging products litigation.

Aaronson Rappaport Feinstein & Deutsch, LLP — selected as a Metropolitan New York first tier law firm by U.S. News - Best Lawyers / Best Law Firms in the fields of Medical Malpractice Defense, Products Liability Defense, Personal Injury Defense and Health Care Law — is a leading litigation firm with one of the most talented and experienced groups of trial partners in New York.

Mr. Sistrunk was selected by his peers for inclusion in The Best Lawyers in America 2015 for his work in the area of Personal Injury Litigation - Plaintiffs and in the 2016 and 2017 editions for his work in the areas of Personal Injury Litigation - Plaintiffs and Products Liability Litigation - Plaintiffs.

Led by co-founders and senior partners Mary Quinn Cooper and William S. Leach, ECSL specializes in commercial litigation, products liability, class actions and complex civil litigation on a regional and national level for clients ranging from small privately owned companies and government entities to Fortune 100 companies.

A frequent speaker on topics including trial strategy, expert witnesses, product liability, and accident reconstruction, Mr. Craft has appeared on television, radio, and in several major newspapers across the country discussing distracted driving, discovery abuse by defendants, vehicle rollovers, roof crush, seatbelts, child restraint systems, airbags, back - over deaths, and other litigation topics.

In September 2014, the firm was recognized by the BTI Consulting Group as a «Standout» in Complex Commercial Litigation and Employment Litigation, ranking among the top 22 and top 18 law firms in the country, respectively, and for its strength in Product Liability Litigation and Securities and Finance Litigation.

He represents clients in complex civil and commercial litigation, including extensive experience in securities litigation, product liability litigation, bankruptcy - related disputes, contract disputes, and disputes involving breaches of fiduciary duties by directors, officers, shareholders and partners.

The firm firm was recognized as Best Lawyers ® «Best Law Firms» by U.S. News & World Report and received the prestigious Tier One ranking for San Diego in the in the categories of Commercial Litigation; Litigation — Construction; Litigation — Real Estate; Mass Torts Litigation / Class Actions; Personal Injury Litigation — Plaintiffs and Product Liability Litigation — Plaintiffs.

Peter has been selected by his peers for a number of years for inclusion in The Best Lawyers in Canada in three areas: commercial insurance; personal injury litigation; and product liability law, and has written, taught and spoken extensively to the legal, insurance and academic communities on insurance, civil litigation and procedure and construction law throughout the course of his career.

Product manufacturers and distributors will find no reprieve from this trend, as a 2009 study commissioned by the Defense Research Institute identified products liability as the leading growth area in tort litigation.

Written by John A. Day, Civil Trial Specialist, 2012 Best Lawyers Bet - the - Company Litigation Lawyer of the Year for Nashville and 2012 Best Lawyers in America listed in Personal Injury, Medical Malpractice, Products Liability, Commercial and Bet - the - Company Litigation, Day on Torts identifies more than 300 Tennessee tort law subjects and provides summary of the leading case on each subject to give you a quick, readable synopsis of current state of the law.

He focuses much of his time on insurance coverage disputes, bad faith defense, lawyer and insurance agent malpractice, business litigation, and catastrophic damages caused by all types of casualty risks, including transportation, construction, product liability, fires, and governmental liability, to name a few.

We have been involved in the development of group litigation in the UK, as pharmaceutical and healthcare product liability cases are often, by their nature, repercussive.

«Strengthening Defense Positions Despite Regulatory Changes Made by the Obama Administration: Overcoming Preemption Hurdles, Accepting Proposed TSCA Changes, and Coming to Terms with Chemical Bans,» American Conference Institute's Chemical Products Liability and Environmental Litigation, Chicago, April 2010

In 2002, our product liability lawyers were appointed by a California Superior Court to the Plaintiffs» Executive Committee overseeing the Sulzer hip implant litigation.

Pfizer's Viagra products liability litigation, an order was issued by the Court (N.D. California) in October of this year regarding the use of TAR.

This year's survey found that labor and employment (particularly, wage and hour litigation), consumer fraud, product liability, and antitrust matters collectively accounted for two - thirds of class action spending by respondents, with data privacy and security matters lurking as a potential next wave in 2018.

Ms. Kroeger has achieved an AV rating from Martindale - Hubbell and has been recognized by Best Lawyers in the field of Product Liability Litigation — Plaintiffs.

Linda J. Chalat of Chalat Hatten & Banker has again been listed by Best Lawyers, appearing in the 2017 Edition of Best Lawyers in America ® in the field of: Product Liability Litigation — Plaintiffs.

After an exhaustive and rigorous peer - review survey comprising nearly 4 million confidential evaluations by the top attorneys in the country, Carrie Frank has been selected for inclusion in the 2012 edition of the Best Lawyers in America for Product Liability Litigation.

In 2016, Mr. Gordon was appointed as Co-Lead Counsel in the national coordinated litigation for MDL 2666, In Re: Bair Hugger Forced Air Warming Devices Products Liability Litigation, by the Honorable Joan Erickslitigation for MDL 2666, In Re: Bair Hugger Forced Air Warming Devices Products Liability Litigation, by the Honorable Joan EricksLitigation, by the Honorable Joan Erickson, D. MN.

It may well be that the coming (and to some extent existing) revolution in genetically individualized medical therapy will require changes in how drugs are evaluated, labeled, etc., but this is a singularity - driven issue that needs to be addressed by the policy branches of our government, and not haphazardly in product liability litigation.

Mr. Beisner was profiled in an article by The American Lawyer that named Skadden as a finalist in the products liability section of its Litigation Department of the Year contest (January 2012).

The Drug and Medical Device Product Liability Deskbook includes: detailed coverage of: warning - related claims and defenses; other information - based theories; strict liability; FDA - related per se liability; preemption of common law tort claims by the Food, Drug & Cosmetic Act and FDA regulations; class actions in drug and medical device litigation; theories of liability asserted against entities other than manufacturers; practical issues involving litigation management; the use of expert witnesses; and many other importanLiability Deskbook includes: detailed coverage of: warning - related claims and defenses; other information - based theories; strict liability; FDA - related per se liability; preemption of common law tort claims by the Food, Drug & Cosmetic Act and FDA regulations; class actions in drug and medical device litigation; theories of liability asserted against entities other than manufacturers; practical issues involving litigation management; the use of expert witnesses; and many other importanliability; FDA - related per se liability; preemption of common law tort claims by the Food, Drug & Cosmetic Act and FDA regulations; class actions in drug and medical device litigation; theories of liability asserted against entities other than manufacturers; practical issues involving litigation management; the use of expert witnesses; and many other importanliability; preemption of common law tort claims by the Food, Drug & Cosmetic Act and FDA regulations; class actions in drug and medical device litigation; theories of liability asserted against entities other than manufacturers; practical issues involving litigation management; the use of expert witnesses; and many other importanliability asserted against entities other than manufacturers; practical issues involving litigation management; the use of expert witnesses; and many other important topics.

Widely regarded by his peers as one of the nation's top trial lawyers and with nearly fifty years of experience representing victims, Thomas V. Girardi has obtained numerous multi-million dollar verdicts and settlements, handling claims involving wrongful death, commercial litigation, products liability, bad faith insurance, and toxic torts.

Ms. Birnbaum has been chosen as the leading product liability lawyer in the world by The International Who's Who of Product Liability Defence Lawyers each year since its inception in 2005 and has been repeatedly selected for inclusion in The Best Lawyers in America for personal injury and mass tort litiproduct liability lawyer in the world by The International Who's Who of Product Liability Defence Lawyers each year since its inception in 2005 and has been repeatedly selected for inclusion in The Best Lawyers in America for personal injury and mass tort liliability lawyer in the world by The International Who's Who of Product Liability Defence Lawyers each year since its inception in 2005 and has been repeatedly selected for inclusion in The Best Lawyers in America for personal injury and mass tort litiProduct Liability Defence Lawyers each year since its inception in 2005 and has been repeatedly selected for inclusion in The Best Lawyers in America for personal injury and mass tort liLiability Defence Lawyers each year since its inception in 2005 and has been repeatedly selected for inclusion in The Best Lawyers in America for personal injury and mass tort litigation.

«Johnson & Johnson and subsidiary Ethicon Inc. on April 13 opposed a motion by nine plaintiffs to centralize federal lawsuits alleging injury from the Physiomesh Flexible Composite hernia patch (In Re: Ethicon Physiomesh Flexible Composite Hernia Mesh Products Liability Litigation, MDL Docket No. 2782, JPMDL).»

This firm helped defend GM during product liability litigation over the faulty ignition switches, viciously fighting families who sued the company and winning the company immunity for injuries and deaths caused by its pre-2009 crashes (including those involving cars with faulty ignition switches).

Legal Times: «Wednesday's decisive Supreme Court ruling against Wyeth in a landmark pharmaceutical product liability case may also close off a major front in a hard - fought battle by businesses and the Bush administration to insulate national corporations from state tort litigation.»

He was appointed by U.S. District Judge Federico A. Moreno to serve as one of the lead counsel in the massive Takata airbag product liability multidistrict litigation, the largest recall in history.

Bowman and Brooke has once again been ranked by Chambers USA in the areas of product liability and mass tort litigation.

Decades of products liability litigation has made the industrial workplace safer by sending engineers back to the drawing board to design newer and safer machines.